Abstract：
UNASSIGNED: Anxiety is a common and disabling condition that significantly impacts quality of life. Subsyndromal anxiety (SSA) refers to anxiety symptoms that do not meet the full diagnostic criteria for an anxiety disorder but pose a risk for developing such disorders. We aimed to provide practical recommendations for the treatment of SSA in primary care settings.
UNASSIGNED: A narrative review was conducted to identify strategies for recognizing and treating patients with SSA.
UNASSIGNED: The recommendations for treating SSA include lifestyle modifications such as exercise and stress reduction techniques, psychotherapy, and pharmacological treatments, including natural compounds like the lavender oil extract Silexan. Regular follow-up care is essential to monitor treatment response and address ongoing symptoms. Additionally, the use of the GAD-7 tool is recommended for accurately identifying patients with SSA.
UNASSIGNED: Implementing these recommendations in primary care can lead to effective treatment of SSA, preventing the development of more severe anxiety disorders. An integrative approach, combining lifestyle modifications, psychotherapy, and pharmacotherapy, including natural compounds, offers significant benefits for managing anxiety.
Anxiety is prevalent and disablingSubsyndromal anxiety is a risk factor for anxiety disordersSubsyndromal anxiety can be assessed with the GAD-7 (Generalised Anxiety Disorder-7 scale)Subsyndromal anxiety can be treated with life-style modification, psychotherapy and pharmacological treatment, including silexan, a natural compound.
UNASSIGNED: A narrative review was conducted to identify strategies for recognizing and treating patients with SSA.
UNASSIGNED: The recommendations for treating SSA include lifestyle modifications such as exercise and stress reduction techniques, psychotherapy, and pharmacological treatments, including natural compounds like the lavender oil extract Silexan. Regular follow-up care is essential to monitor treatment response and address ongoing symptoms. Additionally, the use of the GAD-7 tool is recommended for accurately identifying patients with SSA.
UNASSIGNED: Implementing these recommendations in primary care can lead to effective treatment of SSA, preventing the development of more severe anxiety disorders. An integrative approach, combining lifestyle modifications, psychotherapy, and pharmacotherapy, including natural compounds, offers significant benefits for managing anxiety.
Anxiety is prevalent and disablingSubsyndromal anxiety is a risk factor for anxiety disordersSubsyndromal anxiety can be assessed with the GAD-7 (Generalised Anxiety Disorder-7 scale)Subsyndromal anxiety can be treated with life-style modification, psychotherapy and pharmacological treatment, including silexan, a natural compound.
摘要：
焦虑是一种常见且致残的疾病，严重影响生活质量。亚综合征焦虑(SSA)是指不符合焦虑症的全部诊断标准但具有发展此类疾病的风险的焦虑症状。我们旨在为初级保健机构中SSA的治疗提供实用建议。
■进行了叙述性综述，以确定识别和治疗SSA患者的策略。
■治疗SSA的建议包括改变生活方式，如运动和减压技术，心理治疗,和药物治疗，包括天然化合物，如薰衣草油提取物Silexan。定期随访护理对于监测治疗反应和解决持续症状至关重要。此外,建议使用GAD-7工具准确识别SSA患者.
■在初级保健中实施这些建议可以导致SSA的有效治疗，预防更严重的焦虑症的发展。综合方法，结合生活方式的改变，心理治疗,和药物治疗，包括天然化合物,为管理焦虑提供了显著的好处。
焦虑是普遍存在的，消除亚显焦虑是焦虑障碍的危险因素。亚显焦虑可以用GAD-7（广义焦虑症-7量表）评估亚显焦虑可以用生活方式改变来治疗。心理治疗和药物治疗，包括Silexan,一种天然化合物.
■进行了叙述性综述，以确定识别和治疗SSA患者的策略。
■治疗SSA的建议包括改变生活方式，如运动和减压技术，心理治疗,和药物治疗，包括天然化合物，如薰衣草油提取物Silexan。定期随访护理对于监测治疗反应和解决持续症状至关重要。此外,建议使用GAD-7工具准确识别SSA患者.
■在初级保健中实施这些建议可以导致SSA的有效治疗，预防更严重的焦虑症的发展。综合方法，结合生活方式的改变，心理治疗,和药物治疗，包括天然化合物,为管理焦虑提供了显著的好处。
焦虑是普遍存在的，消除亚显焦虑是焦虑障碍的危险因素。亚显焦虑可以用GAD-7（广义焦虑症-7量表）评估亚显焦虑可以用生活方式改变来治疗。心理治疗和药物治疗，包括Silexan,一种天然化合物.
